Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder TrialsBusiness Wire • 02/20/26
Most Meta staff to get 5% less in equity rewards as Zuckerberg cuts costs for AI spending, FT reportsReuters • 02/19/26
Meta Platforms Taps NVIDIA for AI Expansion: Buy or Hold META Stock?Zacks Investment Research • 02/19/26
Billionaire Stanley Druckenmiller Sells Meta Platforms Stock and Buys an AI Stock Up 210,000% Since Its IPOThe Motley Fool • 02/19/26
Zuckerberg Defiant In Social Media Trial Testimony: “I'm Focused On Building A Community That Is Sustainable”Deadline • 02/19/26